Julia Szulim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Julia Szulim has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Barszcz
Polska
6 shared publications - Ewa Biełanowicz
Cardinal Stefan Wyszynski University - Collegium Medicum, Warsaw, Poland
6 shared publications - Kacper Petelicki
Cardinal Stefan Wyszynski University - Collegium Medicum, ul. Dewajtis 5, 01-815 Warsaw, Poland
6 shared publications - Wojciech Pondo
Lekarze Specjaliści Sp. z o.o., ul. Topolowa 7, 20-352 Lublin, Poland
6 shared publications Agnieszka Tora
Cardinal Stefan Wyszynski University - Collegium Medicum, Warsaw, Poland
3 shared publications- Agnieszka Tora
Cardinal Stefan Wyszynski University - Collegium Medicum, Warsaw, Poland
3 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
SERUM URIC ACID AS A RISK FACTOR FOR CARDIOMETABOLIC DISEASE IN CHILDREN: A SYSTEMATIC REVIEW
Background: Cardiometabolic diseases (CMD), including obesity, hypertension, and metabolic syndrome (MS), are increasingly prevalent in pediatric populations. Early identification of biomarkers associated with cardiometabolic risk is essential for effective prevention. Serum uric acid (UA), traditionally linked to gout and renal disease, has recently emerged as a potential marker and mediator of metabolic dysfunction. Aim: This systematic review aimed to evaluate the relationship between serum UA levels and cardiometabolic risk factors in children and adolescents and to determine whether UA functions as an independent risk factor or a biomarker of CMD. Methods: A systematic literature search was conducted using PubMed, ScienceDirect, and Google Scholar for studies published up to 2025. Keywords included “uric acid,” “children,” “adolescents,” “cardiometabolic risk,” “metabolic syndrome,” “obesity,” “insulin resistance,” and “hypertension.” Eligible studies included original research and reviews involving individuals aged 0–18 years. A qualitative analisys was performed focusing on associations between UA and specific cardiometabolic conditions. Results: Elevated UA levels were consistently associated with obesity, MS, hypertension, and early markers of atherosclerosis in children. UA showed strong correlations with body mass index and waist circumference and may help distinguish between metabolically healthy and unhealthy obesity phenotypes. Higher UA levels were also linked to primary hypertension and appeared to precede its development. Additionally, UA was associated with increased carotid intima–media thickness, suggesting a role in early vascular changes. However, the strength of these associations was sometimes reduced after adjusting for confounding factors such as adiposity and insulin resistance. Conclusions: Serum UA is closely associated with multiple cardiometabolic risk factors in pediatric populations and may serve both as a biomarker and a potential contributor to early disease processes. Although its causal role remains uncertain, UA represents a promising, accessible marker for early risk stratification. Further longitudinal and interventional studies are needed to clarify its clinical utility and determine whether reducing UA levels can improve cardiometabolic outcomes in children.
- 24 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
Open AccessSERUM URIC ACID AS A RISK FACTOR FOR CARDIOMETABOLIC DISEASE IN CHILDREN: A SYSTEMATIC REVIEW
Background: Cardiometabolic diseases (CMD), including obesity, hypertension, and metabolic syndrome (MS), are increasingly prevalent in pediatric populations. Early identification of biomarkers associated with cardiometabolic risk is essential for effective prevention. Serum uric acid (UA), traditionally linked to gout and renal disease, has recently emerged as a potential marker and mediator of metabolic dysfunction. Aim: This systematic review aimed to evaluate the relationship between serum UA levels and cardiometabolic risk factors in children and adolescents and to determine whether UA functions as an independent risk factor or a biomarker of CMD. Methods: A systematic literature search was conducted using PubMed, ScienceDirect, and Google Scholar for studies published up to 2025. Keywords included “uric acid,” “children,” “adolescents,” “cardiometabolic risk,” “metabolic syndrome,” “obesity,” “insulin resistance,” and “hypertension.” Eligible studies included original research and reviews involving individuals aged 0–18 years. A qualitative analisys was performed focusing on associations between UA and specific cardiometabolic conditions. Results: Elevated UA levels were consistently associated with obesity, MS, hypertension, and early markers of atherosclerosis in children. UA showed strong correlations with body mass index and waist circumference and may help distinguish between metabolically healthy and unhealthy obesity phenotypes. Higher UA levels were also linked to primary hypertension and appeared to precede its development. Additionally, UA was associated with increased carotid intima–media thickness, suggesting a role in early vascular changes. However, the strength of these associations was sometimes reduced after adjusting for confounding factors such as adiposity and insulin resistance. Conclusions: Serum UA is closely associated with multiple cardiometabolic risk factors in pediatric populations and may serve both as a biomarker and a potential contributor to early disease processes. Although its causal role remains uncertain, UA represents a promising, accessible marker for early risk stratification. Further longitudinal and interventional studies are needed to clarify its clinical utility and determine whether reducing UA levels can improve cardiometabolic outcomes in children.
- Open Access
- 14 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 72, 74917
Adolescence as a Unique Period of Vulnerability to Anabolic-Androgenic Steroid Exposure: A Narrative Review
Introduction. The non-medical use of anabolic-androgenic steroids (AAS) is an increasingly important public health concern among adolescents, particularly males engaged in resistance training, appearance-oriented sports, and social media-driven muscularity culture. Adolescence represents a period of increased vulnerability because exposure to supraphysiological androgen concentrations occurs during ongoing endocrine, skeletal, reproductive, cardiovascular, and neuropsychiatric development. This narrative review synthesizes current evidence on the health consequences of adolescent AAS exposure, focusing on endocrine disruption, cardiovascular, neuropsychiatric, and musculoskeletal complications, developmental vulnerability, and long-term health risks. Brief description. Available evidence indicates that AAS exposure may suppress the hypothalamic-pituitary-gonadal axis, impair spermatogenesis, contribute to hypogonadism, and disrupt pubertal maturation. Reported cardiovascular complications include dyslipidaemia, hypertension, myocardial remodelling, cardiomyopathy, and increased cardiovascular risk. Neuropsychiatric effects include aggression, mood disturbances, dependence, withdrawal syndromes, and body image-related psychopathology. Additional concerns include hepatotoxicity, renal injury, gynecomastia, premature epiphyseal closure, and tendon rupture. However, direct evidence in adolescents remains limited, and many long-term risks are extrapolated from adult cohorts and developmental biology. Conclusions. Adolescents should not be regarded simply as younger adult AAS users. Exposure during adolescence may disrupt critical biological and psychological development, potentially resulting in long-term health consequences. Prevention should emphasize early education, identification of body image-related risk factors, and multidisciplinary interventions targeting both health behaviours and psychosocial vulnerabilities.
- 14 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 72, 74917
Open AccessAdolescence as a Unique Period of Vulnerability to Anabolic-Androgenic Steroid Exposure: A Narrative Review
Introduction. The non-medical use of anabolic-androgenic steroids (AAS) is an increasingly important public health concern among adolescents, particularly males engaged in resistance training, appearance-oriented sports, and social media-driven muscularity culture. Adolescence represents a period of increased vulnerability because exposure to supraphysiological androgen concentrations occurs during ongoing endocrine, skeletal, reproductive, cardiovascular, and neuropsychiatric development. This narrative review synthesizes current evidence on the health consequences of adolescent AAS exposure, focusing on endocrine disruption, cardiovascular, neuropsychiatric, and musculoskeletal complications, developmental vulnerability, and long-term health risks. Brief description. Available evidence indicates that AAS exposure may suppress the hypothalamic-pituitary-gonadal axis, impair spermatogenesis, contribute to hypogonadism, and disrupt pubertal maturation. Reported cardiovascular complications include dyslipidaemia, hypertension, myocardial remodelling, cardiomyopathy, and increased cardiovascular risk. Neuropsychiatric effects include aggression, mood disturbances, dependence, withdrawal syndromes, and body image-related psychopathology. Additional concerns include hepatotoxicity, renal injury, gynecomastia, premature epiphyseal closure, and tendon rupture. However, direct evidence in adolescents remains limited, and many long-term risks are extrapolated from adult cohorts and developmental biology. Conclusions. Adolescents should not be regarded simply as younger adult AAS users. Exposure during adolescence may disrupt critical biological and psychological development, potentially resulting in long-term health consequences. Prevention should emphasize early education, identification of body image-related risk factors, and multidisciplinary interventions targeting both health behaviours and psychosocial vulnerabilities.
- Open Access
- 8 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 61, 72991
Molar Incisor Hypomineralization (MIH): Etiology, Epidemiology and Global Prevalence – a Narrative Review
Molar Incisor Hypomineralization (MIH) is a developmental enamel defect affecting first permanent molars and often incisors. Recognized by the European Academy of Paediatric Dentistry in 2003, it is now considered a global public health issue associated with hypersensitivity, rapid caries progression, enamel breakdown, and reduced quality of life in children. To summarize current knowledge on the etiology and epidemiology of MIH, focusing on genetic and environmental risk factors and global prevalence.Material and methods. A literature review was conducted using PubMed, Scopus, and Web of Science databases (2003–2025). Keywords included “MIH”, “hypomineralization”, “etiology”, and “prevalence”. Original studies and reviews in English were included; duplicates and studies without clear diagnostic criteria were excluded. Global MIH prevalence ranges from 9% to 14%, with regional variation (higher in South America, lower in Africa). It mainly affects children aged 6–10 years, with no consistent gender differences. Etiology is multifactorial, involving prenatal (maternal illness), perinatal (prematurity, hypoxia), and postnatal factors (infections, antibiotics). Genetic susceptibility involves genes related to enamel formation and immune response. Environmental factors such as dioxins and bisphenol A may contribute.Conclusions. MIH is a common enamel disorder with complex etiology involving gene–environment interactions. Further standardized and longitudinal studies are needed to improve understanding, diagnosis, and prevention.
- 8 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 61, 72991
Open AccessMolar Incisor Hypomineralization (MIH): Etiology, Epidemiology and Global Prevalence – a Narrative Review
Molar Incisor Hypomineralization (MIH) is a developmental enamel defect affecting first permanent molars and often incisors. Recognized by the European Academy of Paediatric Dentistry in 2003, it is now considered a global public health issue associated with hypersensitivity, rapid caries progression, enamel breakdown, and reduced quality of life in children. To summarize current knowledge on the etiology and epidemiology of MIH, focusing on genetic and environmental risk factors and global prevalence.Material and methods. A literature review was conducted using PubMed, Scopus, and Web of Science databases (2003–2025). Keywords included “MIH”, “hypomineralization”, “etiology”, and “prevalence”. Original studies and reviews in English were included; duplicates and studies without clear diagnostic criteria were excluded. Global MIH prevalence ranges from 9% to 14%, with regional variation (higher in South America, lower in Africa). It mainly affects children aged 6–10 years, with no consistent gender differences. Etiology is multifactorial, involving prenatal (maternal illness), perinatal (prematurity, hypoxia), and postnatal factors (infections, antibiotics). Genetic susceptibility involves genes related to enamel formation and immune response. Environmental factors such as dioxins and bisphenol A may contribute.Conclusions. MIH is a common enamel disorder with complex etiology involving gene–environment interactions. Further standardized and longitudinal studies are needed to improve understanding, diagnosis, and prevention.
- Open Access
- 21 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 59, 72755
Sensorimotor Mechanisms of Core Stabilization in the Prevention of Recurrence of Non-Specific Low Back Pain: A Narrative Review
Introduction. Non-specific low back pain (LBP) is characterized by a recurrent clinical course, suggesting persistent functional disturbances rather than isolated episodes of tissue injury. Alterations in neuromuscular control, postural coordination, and anticipatory trunk muscle activation have been documented in individuals with LBP. Importantly, “core stability” remains inconsistently defined and should be interpreted as a systems-based construct involving biomechanical and sensorimotor regulation of trunk function rather than isolated muscle activity alone. This narrative review aimed to synthesize current evidence regarding biomechanical and sensorimotor mechanisms associated with trunk control–oriented exercise interventions and their potential role in preventing recurrence of non-specific LBP in adults.State of knowledge. Current evidence suggests that non-specific LBP is associated with disturbances in feedforward motor control, dysfunction of deep trunk musculature, altered movement coordination, and sensorimotor impairments. Current biomechanical models propose that spinal stability emerges from interactions between passive, active, and neural subsystems. Trunk-focused exercise interventions appear to influence anticipatory activation, intermuscular coordination, and sensorimotor integration, although these effects are more appropriately interpreted as system-level adaptations rather than isolated strengthening effects. Direct evidence linking these mechanisms to reduced recurrence remains limited. Summary. Trunk control–oriented interventions may contribute to recurrence prevention in non-specific LBP primarily through restoration of sensorimotor control and movement coordination rather than increased muscle strength alone. A systems-based interpretation of these interventions may aid in understanding their clinical effects and developing individualized rehabilitation strategies.
- 21 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 59, 72755
Open AccessSensorimotor Mechanisms of Core Stabilization in the Prevention of Recurrence of Non-Specific Low Back Pain: A Narrative Review
Introduction. Non-specific low back pain (LBP) is characterized by a recurrent clinical course, suggesting persistent functional disturbances rather than isolated episodes of tissue injury. Alterations in neuromuscular control, postural coordination, and anticipatory trunk muscle activation have been documented in individuals with LBP. Importantly, “core stability” remains inconsistently defined and should be interpreted as a systems-based construct involving biomechanical and sensorimotor regulation of trunk function rather than isolated muscle activity alone. This narrative review aimed to synthesize current evidence regarding biomechanical and sensorimotor mechanisms associated with trunk control–oriented exercise interventions and their potential role in preventing recurrence of non-specific LBP in adults.State of knowledge. Current evidence suggests that non-specific LBP is associated with disturbances in feedforward motor control, dysfunction of deep trunk musculature, altered movement coordination, and sensorimotor impairments. Current biomechanical models propose that spinal stability emerges from interactions between passive, active, and neural subsystems. Trunk-focused exercise interventions appear to influence anticipatory activation, intermuscular coordination, and sensorimotor integration, although these effects are more appropriately interpreted as system-level adaptations rather than isolated strengthening effects. Direct evidence linking these mechanisms to reduced recurrence remains limited. Summary. Trunk control–oriented interventions may contribute to recurrence prevention in non-specific LBP primarily through restoration of sensorimotor control and movement coordination rather than increased muscle strength alone. A systems-based interpretation of these interventions may aid in understanding their clinical effects and developing individualized rehabilitation strategies.
- Open Access
- 8 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 92
Competitive Running and the Risk of Hip, Knee, and Ankle Osteoarthritis: Cartilage Adaptation, Degeneration, and Joint Replacement Outcomes — A Narrative Review
Introduction and purpose. Running provides well-established cardiovascular and metabolic benefits, but its long-term influence on articular cartilage and osteoarthritis (OA) remains debated, particularly in competitive athletes exposed to high cumulative loading. This narrative review aimed to synthesize current evidence regarding the influence of competitive running on cartilage health, OA risk, and long-term outcomes in the hip, knee, and ankle joints. Brief description of the state of knowledge. Current evidence suggests that recreational running is not consistently associated with increased OA prevalence and may even be protective compared with sedentary behavior. In contrast, competitive and elite running may be associated with higher OA risk, especially when combined with previous injury, excessive training volume, malalignment, elevated body mass index, or biomechanical abnormalities. MRI studies indicate that many exercise-induced cartilage changes are transient and may reflect physiological adaptation rather than irreversible degeneration. Conclusions. Running should not be regarded as a universal independent cause of osteoarthritis. Joint degeneration in runners appears to result from an interaction between cumulative mechanical loading, injury history, biomechanics, recovery capacity, and individual susceptibility. Recreational running is generally compatible with joint health, whereas prolonged high-intensity competitive running may increase degeneration risk in predisposed individuals.
- 8 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 92
Open AccessCompetitive Running and the Risk of Hip, Knee, and Ankle Osteoarthritis: Cartilage Adaptation, Degeneration, and Joint Replacement Outcomes — A Narrative Review
Introduction and purpose. Running provides well-established cardiovascular and metabolic benefits, but its long-term influence on articular cartilage and osteoarthritis (OA) remains debated, particularly in competitive athletes exposed to high cumulative loading. This narrative review aimed to synthesize current evidence regarding the influence of competitive running on cartilage health, OA risk, and long-term outcomes in the hip, knee, and ankle joints. Brief description of the state of knowledge. Current evidence suggests that recreational running is not consistently associated with increased OA prevalence and may even be protective compared with sedentary behavior. In contrast, competitive and elite running may be associated with higher OA risk, especially when combined with previous injury, excessive training volume, malalignment, elevated body mass index, or biomechanical abnormalities. MRI studies indicate that many exercise-induced cartilage changes are transient and may reflect physiological adaptation rather than irreversible degeneration. Conclusions. Running should not be regarded as a universal independent cause of osteoarthritis. Joint degeneration in runners appears to result from an interaction between cumulative mechanical loading, injury history, biomechanics, recovery capacity, and individual susceptibility. Recreational running is generally compatible with joint health, whereas prolonged high-intensity competitive running may increase degeneration risk in predisposed individuals.
- Open Access
- 30 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 56
Low energy availability as a key factor in exercise-induced menstrual dysfunction – a narrative review
Background. Low energy availability (LEA) is increasingly recognized as a key factor underlying physiological disturbances in physically active women, particularly exercise-induced menstrual dysfunction (EIMD). Energy imbalance may impair reproductive function via neuroendocrine disruption of the hypothalamic–pituitary–gonadal axis. Aim. This narrative review synthesizes current evidence on LEA as an etiological factor in EIMD, focusing on physiological mechanisms, spectrum of menstrual disorders, and clinical implications within the Female Athlete Triad and Relative Energy Deficiency in Sport (RED-S) frameworks. Material and methods. A targeted literature search was conducted in PubMed and supplemented by Google Scholar. Over twenty key publications were selected based on relevance and scientific quality, including consensus statements, reviews, and original experimental and observational studies. Results. LEA was identified as the primary driver of EIMD, acting through suppression of gonadotropin-releasing hormone pulsatility and reduced luteinizing hormone secretion. These changes lead to menstrual disturbances ranging from luteal phase defects and anovulation to oligomenorrhea and functional hypothalamic amenorrhea. Evidence suggests that energy deficiency, rather than exercise itself, is the main causal factor. LEA also underlies broader syndromes such as the Female Athlete Triad and RED-S, affecting multiple physiological systems beyond reproduction. Conclusions. LEA is a key modifiable factor in prevention and management of EIMD. Early identification and restoration of adequate energy availability are essential to prevent short- and long-term health consequences in physically active women.
- 30 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 56
Open AccessLow energy availability as a key factor in exercise-induced menstrual dysfunction – a narrative review
Background. Low energy availability (LEA) is increasingly recognized as a key factor underlying physiological disturbances in physically active women, particularly exercise-induced menstrual dysfunction (EIMD). Energy imbalance may impair reproductive function via neuroendocrine disruption of the hypothalamic–pituitary–gonadal axis. Aim. This narrative review synthesizes current evidence on LEA as an etiological factor in EIMD, focusing on physiological mechanisms, spectrum of menstrual disorders, and clinical implications within the Female Athlete Triad and Relative Energy Deficiency in Sport (RED-S) frameworks. Material and methods. A targeted literature search was conducted in PubMed and supplemented by Google Scholar. Over twenty key publications were selected based on relevance and scientific quality, including consensus statements, reviews, and original experimental and observational studies. Results. LEA was identified as the primary driver of EIMD, acting through suppression of gonadotropin-releasing hormone pulsatility and reduced luteinizing hormone secretion. These changes lead to menstrual disturbances ranging from luteal phase defects and anovulation to oligomenorrhea and functional hypothalamic amenorrhea. Evidence suggests that energy deficiency, rather than exercise itself, is the main causal factor. LEA also underlies broader syndromes such as the Female Athlete Triad and RED-S, affecting multiple physiological systems beyond reproduction. Conclusions. LEA is a key modifiable factor in prevention and management of EIMD. Early identification and restoration of adequate energy availability are essential to prevent short- and long-term health consequences in physically active women.